Led regulatory activities for a Class II (EU IIb) medical device (AutoPulse™) and supported global regulatory efforts for Class III public access AEDs
Prepared and submitted regulatory documents, including 510(k) premarket notifications (Traditional 510(k), 510(k) Letter to File) and PMA supplements (30 Day/CMMI, PMA Annual Reports), ensuring FDA compliance
Assisted in the preparation and submission of EU MDD/MDR regulatory documents, such as Technical Files, Design Dossiers, and Clinical Evaluation Reports
Managed new license applications and license renewal submissions for various global markets (e.g., Health Canada, APAC, Brazil, Saudi Arabia)
Supported regulatory dispositioning of product changes, including engineering, design, and labeling changes, to ensure compliance
Developed regulatory strategies for Global Product Management and Marketing teams, identifying risks and growth opportunities for new product development
Monitored global regulatory changes, communicating updates to internal stakeholders and ensuring organization-wide compliance
Participated in internal and external audits, providing regulatory documents and explanations as required
Maintained accurate and up-to-date information for multiple product lines within two Quality Management Systems.
Regulatory Coordinator II
Dana Farber Cancer Institute, DFCI
06.2021 - 02.2022
Organized and led research meetings with Principal Investigator and external institutes to discuss trial status, regulatory information, and patient participant updates
Facilitated communication between DFCI study team, sponsor, and external parties regarding study status, critical safety issues, and protocol, consent, and IDB amendments
Reported major trial changes and routine Annual Reports to FDA as required
Assisted in preparing for DFCI internal IRB audits
Successfully fulfilled all responsibilities of Regulatory Coordinator I role independently, while taking on these additional duties.
Regulatory Coordinator I
Dana Farber Cancer Institute, DFCI
11.2019 - 06.2021
Coordinated protocol submissions and maintained electronic trial master files (TMF) for 12+ breast oncology IND clinical trials, ensuring compliance with DFCI policies, FDA regulations, and Good Clinical Practice (GCP) guidelines
Collected and managed study documents for over 20 external study sites, including personnel changes, investigator changes, and adverse events, for each trial
Tracked and managed new protocols in the study start-up process, ensuring compliance with local and federal benchmarks.
Education
Bachelors - Communication
University of Massachusetts Amherst
05.2018
Skills
Global Regulatory Compliance (FDA Regulations (21 CFR), EU MDD/MDR, ISO standards)